Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder

Date Issued
2006-01-01
Author(s)
Bauer, C
Fischer, A
DOI
10.1111/j.1463-1326.2005.00504.x
Abstract
AIM: In this randomized, double-blind, placebo-controlled study, the effect of sibutramine and cognitive-behavioural weight loss (cognitive-BWL) treatment was assessed in obese subjects with and without subclinical binge eating disorder (sBED). METHODS: Seventy-three obese participants were recruited from the community, 29 with and 44 without sBED. Subjects were randomly assigned to a